The effect of central shielding in the dose reporting for cervical cancer in EQD2 era.
Tharavichitkul E, Wanwilairat S, Watcharawipha A, Tippanya D, Jayasvasti R, Chakrabandhu S, Klunklin P, Onchan W, Galalae R, Chitapanarux I.
Tharavichitkul E, et al.
J Contemp Brachytherapy. 2013 Dec;5(4):236-9. doi: 10.5114/jcb.2013.38781. Epub 2013 Nov 8.
J Contemp Brachytherapy. 2013.
PMID: 24474974
Free PMC article.